Comparative analysis of whole-cell and acellular pertussis vaccines efficacy in preventing pertussis

Comparative analysis of whole-cell and acellular pertussis vaccines efficacy in preventing pertussis

In light of the increasing incidence of pertussis in many countries much attention is paid to vaccines for immunologic prophylaxis of pertussis. The article dwells upon the use of whole-cell and acellular pertussis vaccines (DTPs and DTaPs, respectively). The analyzed materials demonstrate that the...

Full description

Bibliographic Details
Main Authors:	I. A. Alekseeva, O. V. Perelygina
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	цельноклеточная коклюшная вакцина бесклеточная коклюшная вакцина эффективность и безопасность коклюшных вакцин whole-cell pertussis vaccine acellular pertussis vaccine efficacy and safety of pertussis vaccines
Online Access:	https://www.biopreparations.ru/jour/article/view/106

Similar Items

Safety of Combination Vaccines with Whole Cell Pertussis Component
by: O. V. Perelygina, et al.
Published: (2016-12-01)

Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis
by: E. M. Zaitsev, et al.
Published: (2017-04-01)

Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
by: Susanna Esposito, et al.
Published: (2019-07-01)

Acellular Pertussis Vaccine Components: Today and Tomorrow
by: Kalyan K. Dewan, et al.
Published: (2020-05-01)

Acellular and "low" pertussis vaccines: adverse events and the role of mutations Vacinas pertussis acelular e pertussis "low": eventos adversos e o papel das mutações
by: Hisako G. Higashi, et al.
Published: (2009-06-01)

Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting
by: Leah E. Cole, et al.
Published: (2020-12-01)

PROFILES OF CYTOKINES IN MICE DURING IMMUNIZATION WITH ADTP-VACCINE WITH ACELLULAR PERTUSSIS COMPONENT
by: E. M. Zaitsev, et al.
Published: (2016-12-01)

Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review
by: Sabine Vygen-Bonnet, et al.
Published: (2020-02-01)

PERTUSSIS INCIDENCE AND THE EFFECT OF REVACCINATION OF PRESCHOOL AND SCHOOL CHILDREN
by: А. M. Kostinov, et al.
Published: (2018-11-01)

Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
by: Longhuan Ma, et al.
Published: (2021-06-01)

Evaluation of Immunobiological Properties of Bordetella pertussis Vaccine Strains
by: I. A. Alekseeva, et al.
Published: (2018-03-01)

Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative
by: Amar J. Chitkara, et al.
Published: (2020-07-01)

Vacina acelular contra pertússis para adolescentes Acellular pertussis vaccine for adolescents
by: Aroldo P. de Carvalho, et al.
Published: (2006-07-01)

Estimation of Consistency of Production of the Pertussis Component of DTP Vaccine in Terms of Immunogenic Activity and Specific Safety Using Shewhart Charts
by: I. A. Alekseeva, et al.
Published: (2018-12-01)

Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood
by: René H. M. Raeven, et al.
Published: (2019-06-01)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
by: Kevin Markey, et al.
Published: (2019-07-01)

PERTUSSIS IS COMING BACK? IMPROVEMENT OF FORGOTTEN CHILDHOOD INFECTION CONTROL
by: M. V. Fedoseenko, et al.
Published: (2012-04-01)

Pertussis vaccination: problems, possible solutions
by: S. M. Kharit, et al.
Published: (2020-06-01)

New features of pertussis vaccination
by: A. P. Cherdantsev, et al.
Published: (2020-06-01)

Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency
by: María Emilia Gaillard, et al.
Published: (2017-09-01)

The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study
by: Zengguo Wang, et al.
Published: (2020-08-01)

Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
by: Hyo Jin Kwon, et al.
Published: (2017-04-01)

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines
by: Punnee Pitisuttithum, et al.
Published: (2021-07-01)

TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY
by: A. G. Gaivoronskaya, et al.
Published: (2017-02-01)

A Clinical Study of the Safety and Tolerability of Live Nasal Vaccines for the Prevention of Pertussis
by: A. Yu. Medkova, et al.
Published: (2021-02-01)

PERTUSSIS — INFECTION NOT UNDER COMPLETE CONTROL
by: V. K. Tatochenko
Published: (2014-03-01)

Serologic Evidence of Pertussis Infection in Vaccinated Iranian Children
by: Anahita Sanaei Dashti, et al.
Published: (2012-12-01)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
by: Kelsey A. Gregg, et al.
Published: (2019-09-01)

Update on pertussis and pertussis immunization
by: Jung Yun Hong
Published: (2010-05-01)

Pertussis Surveillance in Private Pediatric Practices, France, 2002–2006
by: Nicole Guiso, et al.
Published: (2008-07-01)

Pertussis vaccination of African infants using acellular and whole-cell vaccines.
by: Ramkissoon, Arthi.
Published: (2012)

New combination of methods for isolation and purification of pertussis toxin from the Bordetella pertussis culture
by: Pavlović Katarina B., et al.
Published: (2011-01-01)

Epidemiology of pertussis in Alberta, Canada 2004–2015
by: Xianfang C. Liu, et al.
Published: (2017-06-01)

Risk of Brain Damage Following Pertussis Immunization with Whole-Cell cf Acellular Vaccines
by: J Gordon Millichap
Published: (2004-06-01)

Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France
by: Hélène Bodilis, et al.
Published: (2013-03-01)

The problem of pertussis in some regions of the world
by: A. A Basov, et al.
Published: (2019-07-01)

Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives
by: Violaine Dubois, et al.
Published: (2021-06-01)

Epidemiology of pertussis in Casablanca (Morocco): contribution of conventional and molecular diagnosis tools
by: Khalid Katfy, et al.
Published: (2017-05-01)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
by: Jens Möller, et al.
Published: (2019-06-01)